SCHEMBL14289099

SCHEMBL14289099

CC(C)(C)c1nnnc2cccnc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PRMT5 O14744 1/20 0.35
▸ KDM4E B2RXH2 5/20 0.34
▸ LMNA P02545 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ CCR1 P32246 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ CCR8 P51685 2/20 0.34
▸ GMNN O75496 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MMP8 P22894 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22792600 0.76 HSP90AA1 (0.34) HSP90AA1NPC1L3MBTL1PRMT5KDM4E
SCHEMBL12733328 0.76 EGFR (0.41) HSP90AA1NPC1L3MBTL1PRMT5KDM4E
SCHEMBL9058058 0.75 KDM4E (0.50) HSP90AA1NPC1L3MBTL1PRMT5KDM4E
SCHEMBL16626082 0.75 HSP90AA1 (0.43) HSP90AA1NPC1L3MBTL1PRMT5KDM4E
SCHEMBL14289098 0.74 MAPT (0.39) HSP90AA1NPC1L3MBTL1KDM4ELMNA
SCHEMBL22131166 0.73 PRMT5 (0.41) HSP90AA1NPC1L3MBTL1PRMT5KDM4E
SCHEMBL10327299 0.71 CYP1A2 (0.50) LMNAMAPTHTTCYP2D6SMN1; SMN2
SCHEMBL14314008 0.70 PDE4A (0.38) HSP90AA1NPC1L3MBTL1PRMT5KDM4E
SCHEMBL324632 0.70 KDM4E (0.41) HSP90AA1NPC1L3MBTL1PRMT5KDM4E
SCHEMBL14289097 0.69 TGFBR1 (0.35) HSP90AA1NPC1L3MBTL1PRMT5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004273-A1 Inhibitors of protein tyrosine kinase activity METHYLGENE, INC. (CA) 2008-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004273-A1 Inhibitors of protein tyrosine kinase activity HGF, ERBB2, MET HSP90AA1 898/4885NPC1 3563/4885L3MBTL1 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback